Prevention of heart failure by antihypertensive drug treatment in older persons with isolated systolic hypertension

JAMA

Volumn 278, Issue 3, 1997, Pages 212-216

  Kostis, John B ^a   Davis, Barry R ^b   Cutler, Jeffrey ^c   Grimm, Richard H ^d   Berge, Kenneth G ^e   Cohen, Jerome D ^f   Lacy, Clifton R ^a   Perry, H Mitchell ^f   Blaufox, M Donald ^g   Wassertheil Smoller, Sylvia ^g   Black, Henry R ^h   Schron, Eleanor ^c   Berkson, David M ⁱ   Curb, J David ^j   Smith, W McFate ^k   McDonald, Robert ^l   Applegate, William B ^m  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^d UNIVERSITY OF MINNESOTA   (United States)

^e MAYO CLINIC COLLEGE OF MEDICINE   (United States)

^f WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^h RUSH UNIVERSITY MEDICAL CENTER   (United States)

ⁱ NORTHWESTERN UNIVERSITY   (United States)

^j PACIFIC HEALTH RESEARCH INSTITUTE   (United States)

^k SRI INTERNATIONAL   (United States)

^l UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^m UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; ATENOLOL; CHLORTALIDONE; PLACEBO; RESERPINE;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; ELECTROCARDIOGRAPHY; GERIATRIC PATIENT; HEART FAILURE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MORTALITY; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME;

EID: 0030744599     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.278.3.212     Document Type: Article

References (25)

1. Mortality from congestive heart failure - United States, 1980-1990. MMWR Morb Mortal Wkly Rep. 1994;43:77-81.
2. US Dept of Health and Human Services. Quick Reference Guide for Clinicians 11. Rockville, Md: US Dept of Health and Human Services; 1994.
3. Schocken DD, Arrieta MI, Leaverton PE, Ross EA. Prevalence and mortality rate of congestive heart failure in the United States. J Am Coll Cardiol. 1992;20:301-306.
4. Gillum RF. Heart failure in the United States 1970-1985. Am Heart J. 1987;113:1043-1045.
5. Ho KK, Pinsky JL, Kannel WB, Levy D. The epidemiology of heart failure: the Framingham Study. J Am Coll Cardiol. 1993;22:6A-13A.
6. Levy D, Larson MG, Vasan RS, Kannel WB, Ho KHL The progression from hypertension to congestive heart failure. JAMA. 1996;275:1557-1562.
7. SHEP Cooperative Research. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA. 1991;265:3255-3264.
8. Borhani NO, Applegate WB, Cutler JA, et al. Systolic hypertension in the Elderly Program (SHEP), part 1: rationale and design. Hypertension. 1991;17(suppl):II2-II15.
9. Kostis JB, Berge KG, Davis BR, Hawkins CM, Probstfield J, for the SHEP Cooperative Research Group. Effect of atenolol and reserpine on selected events in the Systolic Hypertension in the Elderly Program (SHEP). Am J Hypertens. 1995;8:1147-1153.
10. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457-481.
11. Cox DR. Regression models and life-tables. J R Stat Soc. 1972;34:187-220.
12. Schoenfeld D. Chi-squared goodness-of-fit tests for the proportional hazards regression model. Biometrika. 1980;67:239-241.
13. Moreau TJ, O'Quigley J, Lellouch J, On D. Schoenfeld's approach for testing the proportional hazard assumption. Biometrika. 1986;73:513-515.
14. Veterans Administration Cooperative Study Group on Antihypertensive Agents. Effects of treatment on morbidity in hypertension: results in patients with diastolic blood pressures averaging 115 through 129 mm Hg. JAMA. 1967;202:1028-1034.
15. Veterans Administration Cooperative Study Group on Antihypertensive Agents. Effects of treatment on morbidity in hypertension, II: results in patients with diastolic blood pressure averaging 90 through 114 mm Hg. JAMA. 1970;213:1143-1151.
16. Dahlof B, Lindholm LH, Hansson L, Schersten B, Ekbom T, Wester PO. Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension). Lancet. 1991;338:1281-1285.
17. The Management Committee of the Australian Therapeutic Trial in Mild Hypertension. The Australian therapeutic trial in mild hypertension. Lancet. 1980;1:1261-1267.
18. Amery A, Brixko P, Clement D, et al. Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly trial. Lancet. 1986;1:1349-1354.
19. Medical Research Council Working Party. Medical Research Council trial of treatment of mild hypertension: principal results. BMJ. 1985;291:97-104.
20. Medical Research Council Working Party. Medical Research Council trial of treatment of hypertension in older adults: principal results. BMJ. 1992;304:405-412.
21. Vasan RS, Benjamin EJ, Levy D. Prevalence, clinical features, and prognosis: an epidemiologic perspective. J Am Coll Cardiol. 1995;26:1565-1574.
22. The SOLVD Investigators. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med. 1992;327:685-691.
23. Pfeffer MA, Braunwald E, Moye LA, et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: results of the Survival and Ventricular Enlargement Trial. N Engl J Med. 1992; 327:669-677.
24. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. Lancet. 1993;342:821-828.
25. Kostis JB. The effect of enalapril on mortal and morbid events in patients with hypertension and left ventricular dysfunction. Am J Hypertens. 1995; 8:909-914.